AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (2.5 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review | Open Access | Online First

Multilayered molecular architecture orchestrating programmed cell death in mucosal barriers tissues

Tao Liu1Qianying Zhang1Duan Chen1Yaoxin Chen1,2Mahmoud Al-Azab3,4Fahmi Shaher5Yuxia Zhang1,6( )Ruchong Chen1,7( )Anny Xiaobo Zhou8( )
State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Joint International Research Laboratory of Respiratory Health, Department of Allergy and Clinical Immunology, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital, Guangzhou Medical University, Guangzhou, 510000, China
The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China
School of Basic Medical Sciences, Guangzhou Women and Children's Medical Centre, Guangzhou Medical University, Guangzhou, 510623, China
Department of Medical Microbiology, Faculty of Medicine, University of Science and Technology, Aden, Yemen
Department of Basic Sciences, Faculty of Medicine, University of Science and Technology, Aden, Yemen
Clinical Research Center for Pediatric Infection and Immunity, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guang Zhou, 510000, China
Guangzhou National Laboratory, Guangzhou, 510000, China
Pulmonary Division, Department of Medicine, Department of Genome Science, School of Medicine, University of Virginia, Charlottesville, VA 22903, USA
Show Author Information

Abstract

Mucosal barrier tissues, including the nasal, respiratory, oral, gastrointestinal, and urinogenital tract, constitute the largest interface between the host and the external environment. These surfaces are continuously exposed to pathogen infection and environmental pollutants. Disruption of mucosal barrier integrity leads to various inflammatory and infectious diseases. Emerging evidence suggests that programmed cell death (PCD) plays a crucial role in shaping the integrity of barrier and local immune responses. In recent years, rapid advances have led to the identification of multiple newly characterized PCD, including apoptosis, necroptosis, autosis, pyroptosis, PANoptosis, ferroptosis, cuproptosis, parthanatos, NETosis, disulfidptosis, entosis, anoikis, methuosis, alkaliptosis, oxeiptosis, lysozincrosis, NECSO (necrosis by sodium overload), and mitoxyperiosis. In this review, we summarize recent advances in PCD, emphasizing their morphological features, activation cascades, and regulatory mechanisms, and discuss their implications in mucosal barrier homeostasis. We further examine how dysregulated PCD contributes to epithelial dysfunction, chronic inflammation, and pathogen infection.

Graphical Abstract

References

【1】
【1】
 
 
Oral Science and Homeostatic Medicine

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Liu T, Zhang Q, Chen D, et al. Multilayered molecular architecture orchestrating programmed cell death in mucosal barriers tissues. Oral Science and Homeostatic Medicine, 2026, https://doi.org/10.26599/OSHM.2026.9610051

31

Views

8

Downloads

0

Crossref

Received: 12 March 2026
Revised: 18 April 2026
Accepted: 23 April 2026
Published: 11 May 2026
© The Author(s) 2026. Published by Tsinghua University Press.

This article is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the original author(s) and the source, provide a link to the license, and indicate if changes were made. See https://creativecommons.org/licenses/by/4.0/